SO-19 S-1 is a cost-effective alternative to capecitabine in metastatic colorectal cancer

Autor: van Oijen, M., Kwakman, R., Punt, C.
Zdroj: In Annals of Oncology July 2020 31 Supplement 3:S224-S224
Databáze: ScienceDirect